Article
Full Access
The Effects of Orally Administered Calcium Pentosan Polysulfate on Inflammation and Cartilage Degradation Produced in Rabbit Joints by Intraarticular Injection of a Hyaluronate—Polylysine Complex
Margaret M. Smith PhD,
Peter Ghosh PhD, FRSC, FRACI,
Yukiko Numata PhD,
Mohinder K. Bansal PhD,
Margaret M. Smith PhD
Raymond Purves Bone and Joint Research Laboratories (University of Sydney) at the Royal North Shore Hospital, Sydney, Australia.
Search for more papers by this authorCorresponding Author
Peter Ghosh PhD, FRSC, FRACI
Raymond Purves Bone and Joint Research Laboratories (University of Sydney) at the Royal North Shore Hospital, Sydney, Australia.
Raymond Purves Bone and Joint Research Laboratories, Royal North Shore Hospital of Sydney, St. Leonards, NSW 2065, AustraliaSearch for more papers by this authorYukiko Numata PhD
Raymond Purves Bone and Joint Research Laboratories (University of Sydney) at the Royal North Shore Hospital, Sydney, Australia.
Search for more papers by this authorMohinder K. Bansal PhD
Raymond Purves Bone and Joint Research Laboratories (University of Sydney) at the Royal North Shore Hospital, Sydney, Australia.
Search for more papers by this authorMargaret M. Smith PhD,
Peter Ghosh PhD, FRSC, FRACI,
Yukiko Numata PhD,
Mohinder K. Bansal PhD,
Margaret M. Smith PhD
Raymond Purves Bone and Joint Research Laboratories (University of Sydney) at the Royal North Shore Hospital, Sydney, Australia.
Search for more papers by this authorCorresponding Author
Peter Ghosh PhD, FRSC, FRACI
Raymond Purves Bone and Joint Research Laboratories (University of Sydney) at the Royal North Shore Hospital, Sydney, Australia.
Raymond Purves Bone and Joint Research Laboratories, Royal North Shore Hospital of Sydney, St. Leonards, NSW 2065, AustraliaSearch for more papers by this authorYukiko Numata PhD
Raymond Purves Bone and Joint Research Laboratories (University of Sydney) at the Royal North Shore Hospital, Sydney, Australia.
Search for more papers by this authorMohinder K. Bansal PhD
Raymond Purves Bone and Joint Research Laboratories (University of Sydney) at the Royal North Shore Hospital, Sydney, Australia.
Search for more papers by this authorAbstract
Objective. To determine the antiinflammatory and cartilage-protecting activities of orally administered calcium pentosan polysulfate (CaPPS) in a rabbit model of inflammatory arthritis.
Methods. A single intraarticular injection of a preformed polycation complex (PC) of poly-D-lysine and hyaluronan was used to induce joint inflammation; saline was injected into the contralateral joint as a control. Animals were killed 1, 4, 7, or 10 days post—PC injection. CaPPS, at 5 mg/kg, 10 mg/kg, or 75 mg/kg, was given every 48 hours commencing 7 days prior to PC injection. Serum interleukin-6 (IL-6), synovial fluid (SF) prostaglandin E2, cell numbers, and cartilage proteoglycan (PG) content, composition, and biosynthesis were determined for PC- and saline-injected joints.
Results. In PC-injected, non—drug-treated animals, serum IL-6 activity, SF leukocyte numbers, and prostaglandin E2 levels were elevated, while cartilage PG content and biosynthesis were reduced. CaPPS at 10 mg/kg, but not at 5 mg/kg, decreased serum IL-6 levels but maintained cartilage PG concentration and biosynthesis. However, SF leukocyte counts and prostaglandin E2 levels (except on day 1) were not reduced.
Conclusion. The ability of CaPPS to attenuate serum IL-6 levels and preserve cartilage PGs in inflamed rabbit joints suggests that this substance could be of value as an effective orally administered chondroprotective, antiarthritic drug.
References
- 1 Bayliss MT: Biochemical changes in human osteoarthritic cartilage, Studies in Osteoarthritis: Pathogenesis, Intervention, Assessment. Edited by DJ Lott, MK Jasani, GFB Birdwood. Chichester, John Wiley and Sons, 1987
- 2 Poole AR: Changes in collagen and proteoglycans of articular cartilage in arthritis. Rheumatology 10: 316–371, 1986
- 3 Mow VC, Ratcliffe A, Poole AR: Cartilage and diarthrodial joints as paradigms for hierarchical materials and structures. Biomaterials 13: 67–97, 1992
- 4 Grushko G, Schneiderman R, Maroudas A: Some biochemical and biophysical parameters for the study of the pathogenesis of osteoarthritis: a comparison between the processes of ageing and degeneration in human hip cartilage. Connect Tissue Res 19: 149–176, 1989
- 5 Glant TT, Mikecz K, Kuettner KE, Thonar EJ-MA: Immune responses to cartilage proteoglycans in inflammatory animal models and human diseases, Joint Cartilage Degradation: Basic and Clinical Aspects. Edited by F Woessner, D Howell. New York, Marcel Dekker, 1992
- 6 Haraoui B, Pelletier J-P, Cloutier J-M, Faure M-P, Martel-Pelletier J: Synovial membrane histology and immunopathology in rheumatoid arthritis and osteoarthritis: in vivo effects of antirheumatic drugs. Arthritis Rheum 34: 153–163, 1991
- 7 Weissmann G: Pathogenesis of inflammation: effects of the pharmacological manipulation of arachidonic acid metabolism on the cytological response to inflammatory stimuli. Drugs 33 (suppl 1): 28–37, 1987
- 8 Burkhardt D, Ghosh P: Laboratory evaluation of anti-arthritic drugs as potential chondroprotective agents. Semin Arthritis Rheum 17 (suppl 1): 3–34, 1987
- 9 Brandt KD: Effects of nonsteroidal anti-inflammatory drugs on chondrocyte metabolism in vitro and in vivo. Am J Med 83: 29–34, 1987
- 10 Ghosh P: Anti-rheumatic drugs and cartilage, Bailliere's Clinical Rheumatology International Practice and Research. Edited by PM Brooks. London, Bailliere Tindall, 1988
- 11 Kalbhen DA: The influence of NSAIDs on morphology of articular cartilage. Scand J Rheumatol Suppl 77: 13–22, 1988
- 12 Francis DJ, Read RA: Pentosan polysulphate ( Cartrophen Vet, Anarthron): its use as a treatment for osteoarthritis (degenerative joint disease) in dogs. Aust Vet Practice 23: 104–109, 1993
- 13 Ghosh P, Smith M, Wells C: Second line agents in osteoarthritis, Second Line Agents in the Treatment of Rheumatic Diseases. Edited by J Dixon, D Furst. New York, Marcel Dekker, 1992
- 14 Rejholec V: Long-term studies of antiosteoarthritic drugs: an assessment. Semin Arthritis Rheum 17 (suppl 1): 35–53, 1987
- 15 Klöcking H-P, Hauptmann J, Richter M: Profibrinolytic and anticoagulant properties of the pentosan polysulphate derivative bego 0391. Pharmazie 46: 543–544, 1991
- 16 Page-Thomas DP: Aspects of experimental inflammatory arthritis, Rheumatoid Arthritis. Edited by J Gordon, B Hazleman. Amsterdam, Elsevier/North-Holland Biomedical Press, 1977
- 17 Cambray GJ, Murphy G, Page-Thomas DP, Reynolds JJ: The production in culture of metalloproteinase and an inhibitor by joint tissues from normal rabbits, and from rabbits with a model arthritis. I. Synovium. Rheumatol Int 1: 11–16, 1981
- 18 Murphy G, Cambray GJ, Virani N, Page-Thomas DP, Reynolds JJ: The production in culture of metalloproteinases and an inhibitor by joint tissues from normal rabbits, and from rabbits with a model arthritis. II. Articular cartilage. Rheumatol Int 1: 17–20, 1981
- 19 Cambray GJ, Murphy G, Reynolds JJ: The effects of dexamethasone in vitro on the production of collagenase and inhibitor by synovial and cartilage explants from the joints of rabbits with a proliferative arthritis. Rheumatol Int 1: 69–72, 1981
- 20 Henderson B, Pettipher ER, Murphy G: Metalloproteinases and cartilage proteoglycan depletion in chronic arthritis: comparison of antigen-induced and polycation-induced arthritis. Arthritis Rheum 33: 241–246, 1990
- 21 Birkedal-Hansen H, Moore WGI, Bodden MK, Windsor LJ, Birkedal-Hansen B, De Carlo A, Engler JA: Matrix metalloproteinases: a review. Crit Rev Oral Biol 4: 197–250, 1993
- 22 Dean DD: Proteinase-mediated cartilage degradation in osteoarthritis. Semin Arthritis Rheum 20: 2–11, 1991
- 23 Martel-Pelletier J, Pelletier J-P, Malemud CJ: Activation of neutral metalloprotease in human osteoarthritic knee cartilage: evidence for degradation in the core protein of sulphated proteoglycan. Ann Rheum Dis 47: 801–808, 1988
- 24 Collier S, Ghosh P: Evaluation of the effects of antiarthritic drugs on the secretion of proteoglycans by lapine chondrocytes using a novel assay procedure. Ann Rheum Dis 48: 372–381, 1989
- 25 Hutadilok N, Smith M, Cullis-Hill D, Ghosh P: Pentosan polysulphate stimulates hyaluronate and DNA synthesis in synovial fibroblasts and partially reduces the suppressive effect of hydrocortisone on fibroblast metabolism. Curr Ther Res 44: 845–860, 1988
- 26 Van Snick J, Cayphas S, Vink A, Uyttenhove C, Coulie PG, Rubira MR, Simpson RJ: Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas. Proc Natl Acad Sci USA 83: 9679–9683, 1986
- 27 Blumenkrantz N, Asboe-Hansen G: New method for quantitative determination of uronic acids. Anal Biochem 54: 484–489, 1973
- 28 Ghosh P, Bushell GR, Taylor TKF, Pearce RH, Grimmer BJ: Distribution of glycosaminoglycans across the normal and the scoliotic disc. Spine 5: 310–317, 1980
- 29 Hope N, Ghosh P, Taylor TKF, Sun D, Read R: The effects of intraarticularly administered hyaluronan on the matrix changes induced in the lateral meniscus by total medial meniscectomy and exercise. Semin Arthritis Rheum 22 (suppl): 43–51, 1993
- 30 Collier S, Ghosh P: Comparison of the effects of non-steroidal anti-inflammatory drugs (NSAIDs) on proteoglycan synthesis by articular cartilage explant and chondrocyte monolayer cultures. Biochem Pharmacol 41: 1375–1384, 1991
- 31 Hovdenes J, Kvien TK, Hovdenes AB: IL-6 in synovial fluids, plasma and supernatants from cultured cells of patients with rheumatoid arthritis and other inflammatory arthritides. Scand J Rheumatol 19: 177–182, 1990
- 32 Waage A, Kaufmann C, Espevik T, Husby G: Interleukin-6 in synovial fluid from patients with arthritis. Clin Immunol Immunopathol 50: 394–398, 1989
- 33 Houssiau FA, Devogelaer J-P, van Damme J, Nagant de Deuxchaisnes C, van Snick J: Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum 31: 784–788, 1988
- 34 Leisten JC, Gaarde WA, Scholz W: Interleukin-6 serum levels correlate with footpad swelling in adjuvant-induced arthritic Lewis rats treated with cyclosporine A or indomethacin. Clin Immunol Immunopathol 56: 108–115, 1990
- 35 Theisen-Popp P, Pape H, Muller-Peddinghaus R: Interleukin-6 (IL-6) in adjuvant arthritis of rats and its pharmacological modulation. Int J Immunol 14: 565–571, 1992
- 36
Ghosh P,
Medved H,
Bansal M,
Haynes D,
Whitehouse M:
In vitro evaluation of action of anti-osteoarthritis drugs (abstract).
Osteoarth Cartilage
1:
10,
1993
10.1016/S1063-4584(05)80130-X Google Scholar
- 37 Bansal MK, Smith MM, Numata Y, Ghosh P: Studies on the effect of calcium pentosan polysulphate (CaPPS) on inflammatory mediators in the rat subcutaneous air-pouch model of inflammation. Curr Ther Res (in press)
- 38 Guerne PA, Zuraw BL, Vaughan JH, Carson DA, Lotz M: Synovium as a source of interleukin 6 in vitro: contribution to local and systemic manifestations of arthritis. J Clin Invest 83: 585–592, 1989
- 39 Edwards JCW, Sedgwick AD, Willoughby DA: The formation of a structure with the features of synovial lining by subcutaneous injection of air: an in vivo tissue culture. J Pathol 134: 147–156, 1981
- 40 Ito A, Itoh Y, Sasaguri Y, Morimatsu M, Mori Y: Effects of interleukin-6 on the metabolism of connective tissue components in rheumatoid synovial fibroblasts. Arthritis Rheum 35: 1197–1201, 1992
- 41 Lotz M, Guerne PA: Interleukin-6 induces the synthesis of tissue inhibitor of metalloproteinases-1/erythroid potentiating activity (TIMP-1/EPA). J Biol Chem 266: 2017–2020, 1991
- 42 Sato T, Ito A, Mori Y: Interleukin 6 enhances the production of tissue inhibitor of metalloproteinases (TIMP) but not that of matrix metalloproteinases by human fibroblasts. Biochem Biophys Res Commun 170: 824–829, 1990
- 43 Duncan MR, Berman B: Stimulation of collagen and glycosaminoglycan production in cultured human adult dermal fibroblasts by recombinant human interleukin-6. J Invest Dermatol 97: 686–692, 1991
- 44 Mihara M, Ikuta M, Koishihara Y, Ohsugi Y: Interleukin 6 inhibits delayed-type hypersensitivity and the development of adjuvant arthritis. Eur J Immunol 21: 2327–2331, 1991
- 45 Chatham WW, Swaim R, Frohsin H Jr, Heck LW, Miller EJ, Blackburn WD Jr: Degradation of human articular cartilage by neutrophils in synovial fluid. Arthritis Rheum 36: 51–58, 1993
- 46 Canning PC, Neill JD: Isolation and characterization of interleukin-1 from bovine polymorphonuclear leukocytes. J Leukoc Biol 45: 21–28, 1989
- 47 Lowther DA, Sriratana A, Baker MS: Effect of inflammation on cartilage metabolism, Articular Cartilage and Osteoarthritis. Edited by K Kuettner, R Schleyerbach, J Peyron, V Hascall. New York, Raven Press, 1991
- 48 Movat HZ, Habal FM, MacMorine RL: Neutral proteases of human PMN leukocytes with kininogenase activity. Int Arch Allergy Appl Immunol 50: 257–281, 1976
- 49 Venge P, Olsson I: Cationic proteins of human granulocytes. VI. Effects on the complement system and mediation of chemotactic activity. J Immunol 115: 1505–1508, 1975
- 50 Baici A, Salgam P, Fehr K, Boni A: Inhibition of human elastase from polymorphonuclear leucocytes by gold sodium thiomalate and pentosan polysulfate. Biochem Pharmacol 30: 703–708, 1981
- 51 Sweet MBE, Thonar EJ-M, Immelman AR, Solomon L: Biochemical changes in progressive osteoarthrosis. Ann Rheum Dis 36: 387–393, 1977
- 52 Kongtawelert P, Brooks P, Ghosh P: Pentosan polysulfate (Cartrophen) prevents the hydrocortisone induced loss of hyaluronic acid and proteoglycans from cartilage of rabbit joints as well as normalizes the keratan sulfate levels in their serum. J Rheumatol 16: 1454–1459, 1989
- 53 Hardingham TE, Muir H: The specific interactions of hyaluronic acid with cartilage proteoglycans. Biochim Biophys Acta 279: 401–405, 1972
- 54 Dingle JT: Cartilage maintenance in osteoarthritis: interaction of cytokines, NSAID and prostaglandins in articular cartilage damage and repair. J Rheumatol 18: 30–37, 1991
- 55 Tyler JA: Cartilage degradation, Cartilage: Molecular Aspects. Edited by B Hall, S Newman. Ann Arbor, CRC Press, 1991
- 56 Rosenberg LC: Structure and function of dermatan sulphate proteoglycans in articular cartilage, Articular Cartilage and Osteoarthritis. Edited by K Kuettner, R Schleyerbach, J Peyron, V Hascall. New York, Raven Press, 1991
- 57 Stanescu V: The small proteoglycans of cartilage matrix. Semin Arthritis Rheum 20: 51–64, 1990
- 58 Sampaio LO, Bayliss MT, Hardingham TE, Muir H: Dermatan sulfate proteoglycan from human articular cartilage: variation in its content with age and its structural comparison with a small chondroitin sulfate proteoglycan from pig laryngeal cartilage. Biochem J 254: 757–764, 1988
- 59 Karvonen RL, Fernandez-Madrid F, Lande MA, Hazlett L, Barrett R, An T, Huebner CJ: Proteoglycans from osteoarthritic human articular cartilage influence type II collagen in vitro fibrillogenesis. Connect Tissue Res 27: 235–250, 1992
- 60 Korver THV, van de Stadt RJ, Kiljan E, van Kampen GP, van der Korst JK: Effects of loading on the synthesis of proteoglycans in different layers of anatomically intact articular cartilage in vitro. J Rheumatol 19: 905–912, 1992
- 61 Little C, Ghosh P, Bellenger C: Meniscectomy increases aggrecan, decorin (PG-S2) and biglycan (PG-S1) metabolism in cartilage (abstract). Trans Orthop Res Soc 18: 707, 1993
- 62 Heino J, Kahari VM, Mauviel A, Krusius T: Human recombinant interleukin-1 regulates cellular mRNA levels of dermatan sulphate proteoglycan core protein. Biochem J 252: 309–312, 1988
- 63 Edwards IJ, Xu H, Wagner WD: Interleukin-1 upregulates decorin production by arterial smooth muscle cells (abstract). Circulation 86: 157, 1992
- 64 Meyer-Carrive I, Ghosh P: Effects of tiaprofenic acid (Surgam) on cartilage proteoglycans in the rabbit joint immobilisation model. Ann Rheum Dis 51: 448–455, 1992
- 65 Lindsley HB, Smith DD: Enhanced prostaglandin E2 secretion by cytokine-stimulated human synoviocytes in the presence of subtherapeutic concentrations of nonsteroidal antiinflammatory drugs. Arthritis Rheum 33: 1162–1169, 1990
